Laplanche S, Diemert M C, Musset L, Abuaf N, Galli J
Service d'Immunochimie, Hôpital de la Salpétrière, Paris.
Ann Biol Clin (Paris). 1990;48(3):177-81.
Anti native DNA antibodies (anti nDNA Ab), which are a highly specific feature of systemic lupus erythematosus (SLE) were measured by 3 methods: an enzyme linked immunosorbent assay (ELISA), an indirect immunofluorescence test on Crithidia luciliae (IFCL) and the Farr assay (reference test). 114 sera from patients with SLE or another connective tissue disease or without autoimmune rheumatic disease were tested. This study showed that ELISA seemed to be a more sensitive and specific test than IFCL (classical test). ELISA was also as sensitive as the Farr assay. ELISA should replace IFCL for the diagnosis and the follow up of patients with SLE. In other connective tissue diseases, ELISA might give more positive results. Thus these had to be confirmed, especially in the case of low antibodies levels, by using another method (e.g., the Farr assay).
采用3种方法检测抗天然DNA抗体(抗nDNA Ab),其为系统性红斑狼疮(SLE)的一个高度特异性特征:酶联免疫吸附测定(ELISA)、利什曼原虫间接免疫荧光试验(IFCL)和Farr试验(参考试验)。检测了114份来自SLE患者、其他结缔组织病患者或无自身免疫性风湿疾病患者的血清。本研究表明,ELISA似乎是比IFCL(经典试验)更敏感和特异的检测方法。ELISA与Farr试验同样敏感。ELISA应取代IFCL用于SLE患者的诊断和随访。在其他结缔组织病中,ELISA可能会给出更多阳性结果。因此,尤其是在抗体水平较低的情况下,必须采用另一种方法(如Farr试验)进行确认。